130 related articles for article (PubMed ID: 26909511)
1. The role of diffusion-weighted magnetic resonance imaging in assessing residual/recurrent cholesteatoma after canal wall down mastoidectomy.
Nash R; Kalan A; Lingam RK; Singh A
Clin Otolaryngol; 2016 Jun; 41(3):307-9. PubMed ID: 26909511
[No Abstract] [Full Text] [Related]
2. Reliability of diffusion-weighted magnetic resonance imaging in differentiation of recurrent cholesteatoma and granulation tissue after intact canal wall mastoidectomy.
Allam HS; Abdel Razek AAK; Ashraf B; Khalek M
J Laryngol Otol; 2019 Dec; 133(12):1083-1086. PubMed ID: 31735177
[TBL] [Abstract][Full Text] [Related]
3. Recidivous cholesteatoma: DWI MR after canal wall up and canal wall down mastoidectomy.
Bakaj T; Zbrozkova LB; Salzman R; Tedla M; Starek I
Bratisl Lek Listy; 2016; 117(9):515-520. PubMed ID: 27677195
[TBL] [Abstract][Full Text] [Related]
4. Using Non-Echoplanar Diffusion Weighted MRI in Detecting Cholesteatoma Following Canal Wall Down Mastoidectomy - Our Experience with 20 Patient Episodes.
Patel B; Hall A; Lingam R; Singh A
J Int Adv Otol; 2018 Aug; 14(2):263-266. PubMed ID: 30256200
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow up after bony mastoid and epitympanic obliteration: radiological findings.
Vercruysse JP; De Foer B; Somers T; Casselman J; Offeciers E
J Laryngol Otol; 2010 Jan; 124(1):37-43. PubMed ID: 19775491
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic Management of Primary Acquired Cholesteatoma.
Chiao W; Chieffe D; Fina M
Otolaryngol Clin North Am; 2021 Feb; 54(1):129-145. PubMed ID: 33131767
[TBL] [Abstract][Full Text] [Related]
7. Non-echoplanar diffusion weighed imaging and T1-weighted imaging for cholesteatoma mastoid extension.
Baba A; Kurihara S; Fukuda T; Yamauchi H; Matsushima S; Ikeda K; Kurokawa R; Ota Y; Takahashi M; Sakurai Y; Motegi M; Komori M; Yamamoto K; Yamamoto Y; Kojima H; Ojiri H
Auris Nasus Larynx; 2021 Oct; 48(5):846-851. PubMed ID: 33461853
[TBL] [Abstract][Full Text] [Related]
8. [Cholesteatoma: rare, but can have serious consequences].
Timmer ML; Borggreven PA; van de Langenberg R; Quak JJ; Colnot DR
Ned Tijdschr Geneeskd; 2020 Apr; 164():. PubMed ID: 32324351
[TBL] [Abstract][Full Text] [Related]
9. Postoperative diffusion weighted MRI and preoperative CT scan fusion for residual cholesteatoma localization.
Alzahrani M; Alhazmi R; Bélair M; Saliba I
Int J Pediatr Otorhinolaryngol; 2016 Nov; 90():259-263. PubMed ID: 27729145
[TBL] [Abstract][Full Text] [Related]
10. MRI, not CT, to rule out recurrent cholesteatoma and avoid unnecessary second-look mastoidectomy.
Migirov L; Tal S; Eyal A; Kronenberg J
Isr Med Assoc J; 2009 Mar; 11(3):144-6. PubMed ID: 19544702
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic accuracy of 1.5 T versus 3 T non-echo-planar diffusion-weighted imaging in the detection of residual or recurrent cholesteatoma in the middle ear and mastoid.
Lips LMJ; Nelemans PJ; Theunissen FMD; Roele E; van Tongeren J; Hof JR; Postma AA
J Neuroradiol; 2020 Nov; 47(6):433-440. PubMed ID: 30951771
[TBL] [Abstract][Full Text] [Related]
12. Use of mastoid obliteration techniques in cholesteatoma.
Yung M; Bennett A
Curr Opin Otolaryngol Head Neck Surg; 2013 Oct; 21(5):455-60. PubMed ID: 23872728
[TBL] [Abstract][Full Text] [Related]
13. Detection of postoperative residual cholesteatoma with non-echo-planar diffusion-weighted magnetic resonance imaging.
De Foer B; Vercruysse JP; Bernaerts A; Deckers F; Pouillon M; Somers T; Casselman J; Offeciers E
Otol Neurotol; 2008 Jun; 29(4):513-7. PubMed ID: 18520587
[TBL] [Abstract][Full Text] [Related]
14. Modified-modified radical mastoidectomy.
Dosemane D; Khadilkar MN; Parvathareddy N
Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3897-3900. PubMed ID: 37195344
[TBL] [Abstract][Full Text] [Related]
15. Acquired middle ear cholesteatoma in children with cleft palate: experience from 18 surgical cases.
Vincenti V; Marra F; Bertoldi B; Tonni D; Saccardi MS; Bacciu S; Pasanisi E
Int J Pediatr Otorhinolaryngol; 2014 Jun; 78(6):918-22. PubMed ID: 24690221
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Mastoid Function with Magnetic Resonance Imaging after Canal Wall Up Cholesteatoma Surgery.
Parkes WJ; Cushing SL; Papsin BC; Blaser SI; James AL
J Int Adv Otol; 2016 Aug; 12(2):132-136. PubMed ID: 27716596
[TBL] [Abstract][Full Text] [Related]
17. Canal wall-down mastoidectomy with mastoid obliteration for pediatric cholesteatoma.
Sun J; Sun J; Hu Y; Lv Q; Wang Y; Li X; Xu W; Wang S; Mei Z; Wan G
Acta Otolaryngol; 2010 Feb; 130(2):259-62. PubMed ID: 19565369
[TBL] [Abstract][Full Text] [Related]
18. Non-EPI DW MRI in planning the surgical approach to primary and recurrent cholesteatoma.
Migirov L; Wolf M; Greenberg G; Eyal A
Otol Neurotol; 2014 Jan; 35(1):121-5. PubMed ID: 24317217
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted imaging for differentiating recurrent cholesteatoma from granulation tissue after mastoidectomy: case report.
Maheshwari S; Mukherji SK
AJNR Am J Neuroradiol; 2002 May; 23(5):847-9. PubMed ID: 12006291
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of temporal subtraction computed tomography and non-echoplanar diffusion-weighted imaging for the mastoid extension of middle ear cholesteatoma.
Baba A; Kurihara S; Kurokawa R; Kurokawa M; Ota Y; Matsushima S; Fukuda T; Yamauchi H; Kano R; Shoji T; Nakazawa T; Yamamoto Y; Kojima H; Srinivasan A; Ojiri H
Auris Nasus Larynx; 2022 Dec; 49(6):956-963. PubMed ID: 35341626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
